Company / R&D Expense
Silo Pharma, Inc. R&D Expense History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$2.4M
FY2025
5-year range
$26.3K / $2.4M
FY2021-FY2025
Trend
+180.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $1M to $2M over the past 2 years.
Based on SEC 10-K filings.
$2M in FY2025 with a 5-year CAGR of +146.1%.
Improved from $1M to $2M over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +146.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +146.1%, indicating consistent growth.
- In FY2025, r&d expense increased 180.2% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.4M | +180.2% |
| FY2024 | $845.1K | -34.3% |
| FY2023 | $1.3M | +4800.7% |
| FY2020 | $26.3K | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026